Clinical trialNCT04472338RecruitingObservational

Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study

SponsorUniversity of WashingtonEnrollment450Prostate Carcinoma

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study investigates ways to detect prostate cancer earlier in people at genetic risk for disease that forms, grows, or spreads quickly (aggressive). Studying samples of blood, urine, and/or tissue in the laboratory may help doctors further understand the genetics of prostate cancer and help identify ways to detect cancer earlier, thereby improving treatment and methods of early detection in the future.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Heather H. Cheng, MD, PhD
Fred Hutch/University of Washington Cancer Consortium
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

City of Hope
Duarte, California, United States
Joanne Jeter, MD
Recruiting
University of California, San Francisco
San Francisco, California, United States
Matthew Cooperberg, MD, MPH
Recruiting
Northwestern
Chicago, Illinois, United States
Edward Schaeffer, MD, PhDHiten Patel, MD, MPH
Recruiting
Massachusetts General Hospital
Boston, Massachusetts, United States
Keyan Salari, MD, PhD
Recruiting
Ohsu Knight Cancer Institute
Portland, Oregon, United States
Alexandra Sokolova, MD
Recruiting
University of Pennsylvania/abramson Cancer Center
Philadelphia, Pennsylvania, United States
Kara Maxwell, MD, PhD
Recruiting
University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States
Terminated
Fred Hutch/university of Washington Cancer Consortium
Seattle, Washington, United States
Heather H. Cheng, MD, PhD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 21 May 2020
Primary completion: 31 Aug 2030
Completion: 31 Aug 2030
Last update posted: 15 May 2026
Registered enrollment: 450
Registry id: NCT04472338

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.